Clinical Trial

Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This observational, multi-center study aims to collect data in order to develop a novel, minimally invasive diagnostic tool for MDS based on peripheral blood profiling of circulating hematopoietic stem and progenitor cells (cHSPCs) using single-cell RNA sequencing and DNA sequencing.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-07-15; most recent amendment 2026-03-22.
Trial Details
NCT Number NCT07081087
Lead Sponsor Weizmann Institute of Science
Conditions Cytopenia, MDS
Enrollment 1,500 participants
Start Date 2025-06-01
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-25